Viewing nowIbandronate Sodium 150 mg (Ibandronic Acid Sodium Hydrate) Tablet
Ibandronate Sodium Monohydrate 168.75mg
Tablet · Prescription medication
Il Dong Pharmaceutical Co., Ltd.

MFDS item code 201205940 · Approved 2012.06.27 · Insurance code 642904480
Improvement of osteoporosis in postmenopausal women
This medication is used for the treatment of osteoporosis in postmenopausal women. Osteoporosis is a condition that weakens bones and increases the risk of fractures, and this medication helps to improve bone strength and reduce the risk of fractures. It is suitable for women whose bones have weakened due to hormonal changes from menopause.
Once a month, take 1 tablet regularly each month on the same day in the morning with a sufficient amount of water at least 1 hour before consuming food, beverages (excluding water), or other oral medications or dietary supplements (including calcium). This medication should be swallowed in an upright position or sitting down with a sufficient amount (180-240 mL) of water, and do not lie down for 60 minutes after taking it. Spring water may reduce the absorption of this medication.
The efficacy and safety in children under 18 have not been studied.
This medication should not be administered to certain patients. For example, individuals allergic to this medication or its ingredients, patients with untreated hypocalcemia, those who cannot sit or stand upright for at least 60 minutes, and patients with esophageal issues making it difficult for food to pass should not use this medication. Additionally, this medication contains lactose, so patients with lactose intolerance or genetic lactose metabolism disorders should not take it. It should be used cautiously in patients with severe renal failure, and a discussion with a physician is essential before administration. During the course of taking this medication, various side effects such as indigestion, nausea, abdominal pain, diarrhea, headache, muscle pain, joint pain, and rash may occur. Most are mild to moderate and do not require discontinuation of treatment. Rarely, serious side effects may occur, such as esophagitis, esophageal ulcers, dizziness, angioedema, and urticaria, so it is important to inform healthcare professionals immediately if any unusual symptoms arise. This medication may irritate the gastrointestinal mucosa, so caution is needed when taken by individuals with gastritis or esophageal issues. It is mandatory to sit or stand upright for at least 60 minutes after taking it, and it is advisable not to take it with food or other medications. As a bisphosphonate, it carries a risk of osteonecrosis of the jaw, so a dental examination should be conducted before dental treatments, and excessive dental work should be avoided. Additionally, severe bone, joint, and muscle pain might occur while taking this medication, and if these symptoms persist, a consultation with a physician is advised. This medication may inhibit absorption when taken with calcium, milk, iron, etc., so it is necessary to avoid consuming other foods or medications for one hour after administration. It is recommended that pregnant or breastfeeding women do not use this medication, and its safety in children or adolescents under 18 has not been established. Overdosage may lead to gastrointestinal disturbances or hypocalcemia, so the dosage must be strictly adhered to, and in case of overdose, do not induce vomiting, and seek medical attention immediately. This medication should be kept out of the reach of children, and expired medications should be disposed of appropriately to avoid environmental damage.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent contact with air or moisture. Additionally, it is best stored at a temperature between 1 and 30 degrees Celsius.
White to almost white oblong film-coated tablets
1 tablet/PTP
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowIbandronate Sodium Monohydrate 168.75mg
Tablet · Prescription medication
Il Dong Pharmaceutical Co., Ltd.

Ibandronate Sodium Monohydrate 168.75mg
Tablet · Prescription medication
Jeil Pharmaceutical Co., Ltd.
Ibandronate Sodium Monohydrate 3.375mg
Solution · Prescription medication
Jeil Pharmaceutical Co., Ltd.

Ibandronate Sodium Monohydrate 168.75mg
Tablet · Prescription medication
Chodang Pharmaceutical Co., Ltd.

Ibandronate Sodium Monohydrate 168.75mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Ibandronate Sodium Monohydrate 168.75mg
Tablet · Prescription medication
Ajou Pharmaceutical Co., Ltd.

Ibandronate Sodium Monohydrate 168.75mg
Tablet · Prescription medication
Aliko Pharmaceutical Co., Ltd.

Ibandronate Sodium Monohydrate 168.75mg
Tablet · Prescription medication
Teragen Etex Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.